Close on 09 Oct 2026
All US Equities (S&P 500 / NASDAQ-100)

West Pharmaceutical Services

WSTUS Listed
Exchange: NYSE · Market: US Equities · Currency: USD

West Pharmaceutical Services (WST) is a leading publicly traded corporation listed in the United States, constituent of the S&P 500 index.

Sector: Health Care·Indices: S&P 500·Market Cap: $25.87B
Close on 16 Oct 2026
$384.02
+1.00 (+0.26%)
Last updated: 16 Oct 2026 (US Market EOD settlement)

Stock Snapshot & Key Numbers — West Pharmaceutical Services

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Up +0.26% on 16 Oct 2026
Position vs 1-Year High
Near 52-Week High
P/E Valuation Multiple
47.1x (Above 40x)
Annual Cash Dividend
0.24% Dividend Yield
Close on 16 Oct 2026
$384.02
+1.00 (+0.26%)vs prev close
1-Year Low to High Range100% of range
Low: $231High: $384
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):47.1x
P/B Ratio (Price / Book):8.7x
Dividend Yield:0.24%
Total Company Value (Market Cap)
$25.87B
Sector: Health Care
Latest Official Announcement:West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com India
1d ago
Plain-English Company Summary

West Pharmaceutical Services (WST) is a US equity security listed on the NYSE. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at $384.02, recording a +1.00 (+0.26%) advance from its previous close of $383.02. Over the trailing 52-week trading cycle, WST has traded between a 52-week low of $230.95 and a 52-week high of $384.02, establishing its annual trading channel. In historical performance, West Pharmaceutical Services has gained 43.73% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +4.92%, 1-month: +6.08%, 6-month: +42.33%, 1-year: +43.73%, 3-year: -0.46%, 5-year: -6.04%. Daily reported trading volume reached 511,200 equity shares. On key valuation multiples as of Oct 13, 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 47.1x and a price-to-book (P/B) ratio of 8.7x, with a trailing dividend yield of 0.24%. Its market capitalization stands at $25.87B. The company is categorized under the Health Care sector and S&P 500 industry within the US equities universe.

Price Chart

1Y: +43.73% (₹116.83)
₹384₹332₹281₹231Thu, 16 Oct, 2025Fri, 16 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Range$230.95 – $384.02
Low: $230.95High: $384.02
$230.95$384.02
Trailing P/E Ratio47.07x
Price to Book (P/B)8.65x
Dividend Yield0.24%
Day High / Low$380.28 – $386.26
Daily Volume0.51M

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
1,234 past 21-day periods analyzed
Fell 24.1%
Within ±5% (44%)
Rose 31.9%
Fell > 5%
24.1%
297 windows
Within ±5%
44%
543 windows
Rose > 5%
31.9%
394 windows
In 80% of past 1 month windows the move was within ±11.6%.
Historical outcomes of this stock's own price. Not a forecast. (1255 trading days of history).
How to read historical odds

At-a-Glance Health & Momentum Check

Market Mood: Expansionary / Momentum
News Activity
DECELERATING
Recent announcement pace
Profit & Margin Trend
EXPANDING
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Expansionary / Momentum
Current market trend
News Tone
NEUTRAL BALANCED
Recent filing tone
What This Means(based on reported financials)

Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.

Active Risk Flags & Monitoring Constraints
Standard systemic equity market and interest rate cycle exposure

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 33.1% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
S&P 500+0.61+0.23Trailing 1Y historical sensitivity: a 1% move in S&P 500 coincided with a +0.61% co-movement (correlation: 0.23). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield-0.29-0.13Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.29% co-movement (correlation: -0.13). Descriptive historical relationship, not predictive.
Brent Crude Oil+0.00+0.00Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.00% co-movement (correlation: -0.00). Descriptive historical relationship, not predictive.
USD / INR-0.05-0.01Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.05% co-movement (correlation: -0.01). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹366.00₹384.02+4.92%
15 Days₹365.01₹384.02+5.21%
1 Month₹362.01₹384.02+6.08%
3 Months₹362.44₹384.02+5.95%
6 Months₹269.81₹384.02+42.33%
1 Year₹267.19₹384.02+43.73%
3 Years₹385.81₹384.02-0.46%
5 Years₹408.72₹384.02-6.04%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
33.1%
Annualized volatility
1Y Beta vs Index
0.61
vs benchmark index
Biggest 1Y Drop
-24.8%
1Y peak-to-low drop
Biggest 5Y Drop
-59.6%
5Y peak-to-low drop
vs 52W High
0.0%
Distance from 1Y high
vs 52W Low
+66.3%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹276.40₹384.02+38.9%
CY 2025₹328.39₹275.14-16.2%
CY 2024₹348.69₹327.56-6.1%
CY 2023₹234.41₹352.12+50.2%
CY 2022₹445.92₹235.35-47.2%
CY 2021₹408.72₹469.01+14.8%

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for WST.

Historical Investment Simulator

Factual simulation of past returns in West Pharmaceutical Services (WST) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹93,956.70
Based on latest close
Absolute Return
-6.0%
₹-6,043.30
Annualized (CAGR)
-1.2%
Compound annual growth
Entry Price: ₹408.72 · Exit Price: ₹384.02
Simulated 5Y period (INR)

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 1 of 1 Updates
#1 GENERALLODR Materiality: 68/100Neutral / RoutineRecent EventDirect Mention
1d ago

West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com India

West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com Investing.com India

Valuation Impact:±0.5% (Neutral Fundamental Range)
Inspecting in Causal Panel
Source: Investing.com India·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Causal Attribution in Focus
GENERAL·1d ago
Verified Exchange / Wire Disclosure:
West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com India
Source: Investing.com India·LODR Materiality: 68/100
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Regulatory & Corporate Disclosure Event
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. WST Accretion
±0.5% (Neutral Fundamental Range)
Causal Attribution Analysis:Direct Named Awardee

Institutional regulatory disclosure or industry observation

Extracted Factual Evidence:
  • •Verified against public financial wire feeds and exchange disclosures
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across health care units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Enterprise Valuation MultiplesMarket Liquidity
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

Common Questions About West Pharmaceutical Services (WST)

Key facts on WST share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of West Pharmaceutical Services (WST)?

As of 16 Oct 2026, the official closing share price of West Pharmaceutical Services (WST) on NYSE is $384.02 (+0.26% vs the previous close). Over the past 52 weeks, WST has traded between a low of $230.95 and a high of $384.02, with a reported market capitalization of $25.87B.

What are the historical returns of West Pharmaceutical Services (WST)?

Based on split-adjusted closing prices through 16 Oct 2026, West Pharmaceutical Services (WST) recorded the following trailing price returns: 1 Week: +4.92% (from $366.00 to $384.02); 15 Days: +5.21% (from $365.01 to $384.02); 1 Month: +6.08% (from $362.01 to $384.02); 3 Months: +5.95% (from $362.44 to $384.02); 6 Months: +42.33% (from $269.81 to $384.02); 1 Year: +43.73% (from $267.19 to $384.02); 3 Years: -0.46% (from $385.81 to $384.02); 5 Years: -6.04% (from $408.72 to $384.02). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of West Pharmaceutical Services (WST)?

West Pharmaceutical Services (WST) currently trades at a trailing Price-to-Earnings (P/E) ratio of 47.1x, a Price-to-Book (P/B) ratio of 8.7x, and a trailing 12-month dividend yield of 0.24%. It operates in the Health Care sector (S&P 500).

How much would a past lump-sum or monthly SIP investment in WST have grown?

Based on historical closing prices for West Pharmaceutical Services (WST): A one-time lump-sum investment of $10000.00 held for 5 years would be worth $9395.67 (-6.0% total return, -1.2% CAGR), while a monthly SIP of $500.00 over 5 years (total invested: $30500.00) would be worth $38196.62 (+25.2% absolute return). You can test custom amounts and holding periods in the interactive calculator above.